SOX2 and prostate carcinoma: Earlier studies reported that ANXA3, ANXA2, and its pseudogene ANXA2P2 are overexpressed in various cancers, including prostate cancer, and facilitated transcription of the stemness genes Nanog, Sox2, and Oct4 (51–53).